Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.

Arthritis research & therapy

Volumn 11, Issue 4, 2009, Pages

  Toms, Tracey E ^a   Panoulas, Vasileios F ^a   John, Holly ^a   Douglas, Karen M J ^a   Kitas, George D ^a  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; METHOTREXATE;

ADULT; AGE; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RHEUMATOID ARTHRITIS;

ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; METHOTREXATE; MIDDLE AGED; PREVALENCE;

EID: 73349127171     PISSN: None     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2765     Document Type: Article

References (0)